One-month follow-up of PDLLA nodule treatment

This article discusses the source author’s earlier literature, cases and experiences. Research populations and limitations matter; individual diagnosis and treatment require clinical assessment.

The source describes one patient treated elsewhere with CaHA across the neck and Juvelook along horizontal lines, followed by palpable lesions. The original states that consent was obtained for its photographs, but permission for this republication still requires confirmation.

The author discusses options encountered in literature, including saline, steroid injections, mechanical approaches, lasers and surgery. Each has different risks, including postinflammatory hyperpigmentation. The course recorded here runs from 29 November to 19 December 2024; “one month” is not a general expected recovery time.

Source photograph dated 29 November 2024.

The author recalls the patient’s distress and describes less firmness, roundness and redness by 19 December after several treatments. Small residual nodules remained and further follow-up was planned. Inflammation and pigmentation can occur, but neither is universal. Treatment and pigment-related assessment need individual review.

Source ultrasound caption: a rounded lesion measured at 0.14cm on 29 November, marked with a yellow dotted line.

The source records visits at variable intervals and a later measurement of 0.04cm on 19 December, with a flatter appearance. Measurement technique and the individual course matter; these changes are not a success rate.

The author records appreciation for the patient’s improvement and a gift received during treatment. The course was still ongoing.

The author notes that bruising or swelling may occur and that scarves can make a neck treatment course less visible. Prayer is described as a personal expression of care, not a cellular treatment mechanism or evidence of efficacy.

The source includes a personal religious quotation. It is not medical evidence.

The source closes by urging caution with collagen-stimulating materials and emphasizing the time, expense and distress that complications can cause. PDLLA, PLLA and CaHA have different properties and should not be regarded as interchangeable.